No title
Glioblastoma (GBM) and ischemic stroke represent two challenging brain pathologies which still lack an optimal therapeutic strategy. Central to these diseases are pericytes, mural cells that regulate blood-brain barrier (BBB) integrity, vascular stability, and immune responses. However, the diseasespecific alterations in pericytes that contribute to GBM progression and their influence on the posts
